Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2001-11-5
pubmed:abstractText
It may be useful to reduce the exposure of transplant recipients to homologous blood. This may be achieved by procuring donor-derived red blood cell (RBC) units, collecting more peripheral blood progenitor cells (PBPC) with a combination of granulocyte colony-stimulating factor (G-CSF) + recombinant human erythropoietin (rHuEpo) and by administering rHuEpo post-transplantation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0390-6078
pubmed:author
pubmed:issnType
Print
pubmed:volume
86
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1209-18
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:11694408-Adolescent, pubmed-meshheading:11694408-Adult, pubmed-meshheading:11694408-Blood Donors, pubmed-meshheading:11694408-Cytapheresis, pubmed-meshheading:11694408-Erythrocyte Transfusion, pubmed-meshheading:11694408-Erythropoietin, pubmed-meshheading:11694408-Feasibility Studies, pubmed-meshheading:11694408-Female, pubmed-meshheading:11694408-Graft Survival, pubmed-meshheading:11694408-Granulocyte Colony-Stimulating Factor, pubmed-meshheading:11694408-Hematopoietic Stem Cell Mobilization, pubmed-meshheading:11694408-Hematopoietic Stem Cell Transplantation, pubmed-meshheading:11694408-Humans, pubmed-meshheading:11694408-Leukapheresis, pubmed-meshheading:11694408-Male, pubmed-meshheading:11694408-Middle Aged, pubmed-meshheading:11694408-Prospective Studies, pubmed-meshheading:11694408-Recombinant Proteins, pubmed-meshheading:11694408-Transplantation, Homologous
pubmed:year
2001
pubmed:articleTitle
Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantation.
pubmed:affiliation
Department of Medicine, Division of Haematology, University of Liège, Liège, Belgium.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't